Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography

被引:23
|
作者
van Oost, FJ
van der Hoeven, JJM
Hoekstra, OS
Voogd, AC
Coebergh, JWW
van de Poll-Franse, LV
机构
[1] Comprehens Canc Ctr S, IKZ, Eindhoven Canc Registry, NL-5600 AE Eindhoven, Netherlands
[2] Ziekenhuis Amstelveen, Dept Internal Med, Amstelveen, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Nucl Med, PET, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[5] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
[6] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
关键词
breast cancer; recurrence; staging; 2-fluoro-2-deoxy-D-glucose; positron emission tomography; PET;
D O I
10.1016/j.ejca.2004.03.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to describe the extent and yield of daily clinical practice when staging patients with a locoregional recurrence (LRR) of breast carcinoma and to explore the prospects for positron emission tomography (PET). The population-based Eindhoven Cancer Registry was used to select all breast cancer patients in the southeast of the Netherlands with a first episode of LRR between January 1, 1994 and June 30, 2000 (n = 175). Additional data concerning staging procedures and follow-up were collected from the medical records. Furthermore, we asked 77 physicians (response: 75%) about their opinions on staging procedures and actual treatment policy. At LRR presentation, 16% of patients were found to have distant metastases. An additional 24% were diagnosed with distant metastases within 18 months. The questionnaire revealed that 33% of clinicians thought that the sensitivity of conventional imaging techniques was too low. We tend to conclude that in daily clinical practice there is a need for more sensitive dissemination tests for patients with a LRR of breast cancer. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1545 / 1553
页数:9
相关论文
共 50 条
  • [31] Cost-effectiveness of positron emission tomography in breast cancer
    Sloka, JS
    Hollett, PD
    Mathews, M
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (05) : 351 - 360
  • [32] The role of positron emission tomography for evaluation of lung nodules and staging lung cancer
    Barbara M. Fischer
    Jann Mortensen
    Current Respiratory Care Reports, 2012, 1 (1): : 30 - 39
  • [33] POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-DEOXYGLUCOSE IN THE DETECTION AND STAGING OF BREAST-CANCER
    NIEWEG, OE
    KIM, EE
    WONG, WH
    BROUSSARD, WF
    SINGLETARY, SE
    HORTOBAGYI, GN
    TILBURY, RS
    CANCER, 1993, 71 (12) : 3920 - 3925
  • [34] Diagnostic value of positron emission tomography for detecting breast cancer
    Noh D.-Y.
    Yun I.-J.
    Kim J.-S.
    Kang H.-S.
    Lee D.-S.
    Chung J.-K.
    Lee M.C.
    Youn Y.-K.
    Oh S.K.
    Choe K.J.
    World Journal of Surgery, 1998, 22 (3) : 223 - 228
  • [35] Imaging mouse models of breast cancer with positron emission tomography
    S Cherry
    C Abbey
    S Borowsky
    J Gregg
    R Cardiff
    Breast Cancer Research, 5 (Suppl 1)
  • [36] The future in diagnosis and staging of lung cancer: Positron emission tomography
    Fischer, Barbara M.
    Mortensen, Jann
    RESPIRATION, 2006, 73 (03) : 267 - 276
  • [37] Comparison of 18F-fluorothymidine Positron Emission Tomography/Computed Tomography and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
    Mori, Mio
    Fujioka, Tomoyuki
    Ichikawa, Ryota
    Inomata, Reina
    Katsuta, Leona
    Yashima, Yuka
    Yamaga, Emi
    Tsuchiya, Junichi
    Hayashi, Kumiko
    Kumaki, Yuichi
    Oda, Goshi
    Nakagawa, Tsuyoshi
    Onishi, Iichiroh
    Kubota, Kazunori
    Tateishi, Ukihide
    TOMOGRAPHY, 2022, 8 (05) : 2533 - 2546
  • [38] The role of positron emission tomography for evaluation of lung nodules and staging lung cancer
    Fischer, Barbara M.
    Mortensen, Jann
    CURRENT PULMONOLOGY REPORTS, 2012, 1 (01) : 30 - 39
  • [39] Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
    Olagunju A. Ogunbiyi
    Fidelma L. Flanagan
    Farrokh Dehdashti
    Barry A. Siegel
    Diane D. Trask
    Elisa H. Birnbaum
    James W. Fleshman
    Thomas E. Read
    Gordon W. Philpott
    Ira J. Kodner
    Annals of Surgical Oncology, 1997, 4 : 613 - 620
  • [40] Cost-Effectiveness of Positron Emission Tomography in Breast Cancer
    J. Scott Sloka
    Peter D. Hollett
    Maria Mathews
    Molecular Imaging and Biology, 2005, 7 : 351 - 360